Story
Twist Bioscience Stock Gains After Joining Eli Lilly's AI Drug Discovery Platform
Shares of Twist Bioscience (NASDAQ: TWST) rallied on Wednesday after the synthetic biology company announced it has joined Eli Lilly's collaborative AI-powered drug discovery platform, TuneLab. The partnership underscores the company's strategic pivot toward AI-driven life sciences and was met with positive investor sentiment.
Partnership Details
Under the agreement, Twist will act as a preferred antibody characterization data provider. The company is tasked with generating high-throughput wet lab antibody data using protocols specified by TuneLab.
This data will feed directly into AbLab, Eli Lilly’s proprietary antibody developability prediction model. The integration is designed to help TuneLab’s more than 75 participating companies more rapidly identify and select promising drug candidate molecules.
Market Impact and Strategy
The collaboration reinforces Twist's growing focus on AI applications. According to the company, the quality of its high-throughput data is essential for training reliable AI models. This news pushed the stock up 3.7% in afternoon trading to $143.15, after reaching an intraday high of $148.50.
AdThe rally continues a significant recovery for the stock, which has climbed from a 52-week low of $23.30. The move also builds on existing bullishness following the company's record third-quarter revenue and raised full-year guidance.
Industry Context
The endorsement from Eli Lilly lends significant credibility to Twist's platform, as the TuneLab ecosystem is backed by Lilly's proprietary research data valued at over $1 billion. The partnership highlights a broader sector-wide trend toward using AI to accelerate pharmaceutical development, with companies like Schrödinger also participating in the TuneLab platform.
A supportive market environment, with the NASDAQ Composite advancing 0.7%, provided a further tailwind for growth and biotech stocks during the session.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.